Masimo Revenue 2007-2020 | MASI

Masimo annual/quarterly revenue history and growth rate from 2007 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Masimo revenue for the quarter ending March 31, 2020 was $0.270B, a 16.39% increase year-over-year.
  • Masimo revenue for the twelve months ending March 31, 2020 was $0.976B, a 11.27% increase year-over-year.
  • Masimo annual revenue for 2019 was $0.938B, a 9.27% increase from 2018.
  • Masimo annual revenue for 2018 was $0.858B, a 8.61% increase from 2017.
  • Masimo annual revenue for 2017 was $0.79B, a 10.85% increase from 2016.
Masimo Annual Revenue
(Millions of US $)
2019 $938
2018 $858
2017 $790
2016 $713
2015 $630
2014 $587
2013 $547
2012 $493
2011 $439
2010 $405
2009 $349
2008 $307
2007 $256
2006 $224
2005 $108
Masimo Quarterly Revenue
(Millions of US $)
2020-03-31 $270
2019-12-31 $248
2019-09-30 $229
2019-06-30 $230
2019-03-31 $232
2018-12-31 $223
2018-09-30 $211
2018-06-30 $212
2018-03-31 $213
2017-12-31 $208
2017-09-30 $193
2017-06-30 $192
2017-03-31 $197
2016-12-31 $201
2016-09-30 $168
2016-06-30 $173
2016-03-31 $171
2015-12-31 $167
2015-09-30 $153
2015-06-30 $156
2015-03-31 $155
2014-12-31 $162
2014-09-30 $144
2014-06-30 $141
2014-03-31 $140
2013-12-31 $142
2013-09-30 $131
2013-06-30 $137
2013-03-31 $136
2012-12-31 $132
2012-09-30 $119
2012-06-30 $123
2012-03-31 $119
2011-12-31 $112
2011-09-30 $104
2011-06-30 $110
2011-03-31 $113
2010-12-31 $106
2010-09-30 $101
2010-06-30 $100
2010-03-31 $99
2009-12-31 $93
2009-09-30 $87
2009-06-30 $84
2009-03-31 $85
2008-12-31 $83
2008-09-30 $78
2008-06-30 $75
2008-03-31 $71
2007-12-31 $69
2007-09-30 $64
2007-06-30 $64
2007-03-31 $59
2006-09-30 $58
2006-06-30 $56
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $12.695B $0.938B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $150.978B 30.66
Intuitive Surgical (ISRG) United States $68.179B 50.36
Edwards Lifesciences (EW) United States $43.085B 36.21
DexCom (DXCM) United States $39.079B 182.40
IDEXX Laboratories (IDXX) United States $28.832B 67.89
ALCON INC (ALC) Switzerland $28.721B 32.15
Fresenius Medical Care AG KGaA (FMS) Germany $26.348B 17.95
Olympus (OCPNY) Japan $26.270B 53.43
Teleflex (TFX) United States $17.092B 31.66
Sysmex ADR (SSMXY) Japan $15.611B 44.00
Hologic (HOLX) United States $14.940B 23.52
SONOVA HOLDING (SONVY) Switzerland $13.957B 0.00
STERIS (STE) Ireland $13.053B 27.24
ABIOMED (ABMD) United States $11.991B 64.30
Varian Medical Systems (VAR) United States $11.131B 27.00
SARTORIUS AG (SARTF) Germany $9.169B 78.82
Penumbra (PEN) United States $6.708B 258.46
Tandem Diabetes Care (TNDM) United States $6.112B 0.00
Globus Medical (GMED) United States $4.448B 28.15
Integra LifeSciences Holdings (IART) United States $4.089B 18.75
Nevro (NVRO) United States $3.997B 0.00
Wright Medical Group (WMGI) Netherlands $3.873B 601.00
Elekta AB (EKTAY) Sweden $3.675B 28.29
Nihon Kohden (NHNKY) Japan $2.694B 0.00
LivaNova (LIVN) United Kingdom $2.522B 19.01
OPKO Health (OPK) United States $2.519B 0.00
Integer Holdings (ITGR) United States $2.349B 14.51
Cantel Medical (CMD) United States $1.900B 21.99
Glaukos (GKOS) United States $1.721B 0.00
ShockWave Medical (SWAV) United States $1.526B 0.00
Luminex (LMNX) United States $1.517B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.453B 28.18
Veracyte (VCYT) United States $1.431B 0.00
Silk Road Medical (SILK) United States $1.340B 0.00
Mesa Laboratories (MLAB) United States $0.978B 51.71
GenMark Diagnostics (GNMK) United States $0.954B 0.00
Accelerate Diagnostics (AXDX) United States $0.886B 0.00
Inogen (INGN) United States $0.823B 49.09
OrthoPediatrics (KIDS) United States $0.780B 0.00
Tactile Systems Technology (TCMD) United States $0.769B 97.54
CryoLife (CRY) United States $0.737B 102.84
Natus Medical (NTUS) United States $0.734B 18.10
Quotient (QTNT) Switzerland $0.633B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.614B 24.81
Pacific Biosciences Of California (PACB) United States $0.606B 0.00
Intersect ENT (XENT) United States $0.460B 0.00
AxoGen (AXGN) United States $0.454B 0.00
Si-Bone (SIBN) United States $0.452B 0.00
Repro-Med Systems (KRMD) United States $0.393B 301.33
AngioDynamics (ANGO) United States $0.391B 26.00
TransMedics (TMDX) United States $0.372B 0.00
Vermillion (AWH) United States $0.357B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.351B 0.00
ViewRay (VRAY) United States $0.332B 0.00
Fluidigm (FLDM) United States $0.309B 0.00
Stereotaxis (STXS) United States $0.304B 0.00
Alphatec Holdings (ATEC) United States $0.300B 0.00
Semler Scientific (SMLR) United States $0.297B 32.83
IRadimed (IRMD) United States $0.292B 31.43
SeaSpine Holdings (SPNE) United States $0.274B 0.00
RTI Surgical (RTIX) United States $0.212B 0.00
Sientra (SIEN) United States $0.198B 0.00
Accuray (ARAY) United States $0.197B 0.00
CRH Medical (CRHM) Canada $0.165B 115.00
T2 Biosystems (TTOO) United States $0.160B 0.00
Electromed (ELMD) United States $0.132B 33.85
Restoration Robotics (VERO) Canada $0.110B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.090B 0.00
EDAP TMS S.A (EDAP) France $0.072B 35.29
ConforMIS (CFMS) United States $0.059B 0.00
MRI Interventions (CLPT) United States $0.055B 0.00
Bioanalytical Systems (BASI) United States $0.055B 0.00
Ekso Bionics Holdings (EKSO) United States $0.054B 0.00
Sensus Healthcare (SRTS) United States $0.049B 0.00
Allied Healthcare Products (AHPI) United States $0.044B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.042B 0.00
Apollo Endosurgery (APEN) United States $0.036B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Neovasc (NVCN) Canada $0.027B 0.00
Delcath Systems (DCTH) United States $0.026B 0.00
DarioHealth (DRIO) Israel $0.024B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.022B 0.00
Second Sight Medical Products (EYES) United States $0.022B 0.00
Sunshine Heart Inc (CHFS) United States $0.021B 0.00
Helius Medical Technologies (HSDT) United States $0.020B 0.00
TransEnterix (TRXC) United States $0.017B 0.00
ReWalk Robotics (RWLK) Israel $0.017B 0.00
Dynatronics (DYNT) United States $0.014B 0.00
Xtant Medical Holdings (XTNT) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.013B 0.00
American Shared Hospital Services (AMS) United States $0.012B 43.60
Lianluo Smart (LLIT) China $0.012B 0.00
Avinger (AVGR) United States $0.011B 0.00
Nanovibronix (NAOV) United States $0.009B 0.00
Viveve Medical (VIVE) United States $0.009B 0.00
Ra Medical Systems (RMED) United States $0.006B 0.00
OBALON THERPTCS (OBLN) United States $0.005B 0.00
InspireMD (NSPR) Israel $0.002B 0.00